Lansdowne Partners (UK)’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $1.46M | Buy |
|
|||||
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $2.43M | Sell |
|
|||||
|
2024
Q1 | $3.84M | Sell |
|
|||||
|
2023
Q4 | $6.86M | Buy |
|
|||||
|
2023
Q3 | $5.99M | Buy |
|
|||||
|
2023
Q2 | $4.31M | Sell |
|
|||||
|
2023
Q1 | $5.76M | Buy |
|
|||||
|
2022
Q4 | $6.47M | Buy |
|
|||||
|
2022
Q3 | $3.4M | Sell |
|
|||||
|
2022
Q2 | $6.5M | Buy |
|
|||||
|
2022
Q1 | $5.34M | Buy |
|